Rossi Christina's Form 4 filing
Blueprint Medicines Corp (BPMC) · filed May 7, 2025
- Accession no.
- 0001415889-25-012250
- Filed
- May 7, 2025
- Trade date
- May 5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $231.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rossi ChristinaCIK 0001756941 | Officer (CHIEF OPERATING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 5, 2025 | Common Stock | SSaleDisposed | −607 | $100.97 | −$61,288.79 | 68,659 | Direct | |
| May 5, 2025 | Common Stock | SSaleDisposed | −1,343 | $101.77 | −$136,677.11 | 67,316 | Direct | |
| May 5, 2025 | Common Stock | SSaleDisposed | −180 | $102.82 | −$18,507.6 | 67,136 | Direct | |
| May 5, 2025 | Common Stock | SSaleDisposed | −144 | $103.56 | −$14,912.64 | 66,992 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.